STOCK TITAN

REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

REGENXBIO (Nasdaq: RGNX) has announced its participation in five major investor conferences during March and April 2025. The company will engage in fireside chat presentations at:

  • TD Cowen's 45th Annual Health Care Conference in Boston (March 5, 1:10pm ET)
  • Leerink Partners Global Healthcare Conference in Miami (March 11, 9:20am ET)
  • Barclays 27th Annual Global Healthcare Conference in Miami (March 12, 3:30pm ET)
  • UBS Virtual CNS Day (March 17, 10:00am ET)
  • RBC Inaugural Virtual Ophthalmology Conference (April 3, 8:15am ET)
  • Select fireside chats will be available via live webcast through REGENXBIO's website, with recordings accessible for approximately 30 days after each presentation.

REGENXBIO (Nasdaq: RGNX) ha annunciato la sua partecipazione a cinque importanti conferenze per investitori durante marzo e aprile 2025. L'azienda parteciperà a presentazioni in formato fireside chat presso:

  • Il 45° Annual Health Care Conference di TD Cowen a Boston (5 marzo, 13:10 ET)
  • Il Global Healthcare Conference di Leerink Partners a Miami (11 marzo, 9:20 ET)
  • Il 27° Annual Global Healthcare Conference di Barclays a Miami (12 marzo, 15:30 ET)
  • UBS Virtual CNS Day (17 marzo, 10:00 ET)
  • La Conferenza Virtuale Inaugurale di Oftalmologia di RBC (3 aprile, 8:15 ET)

Selezionati fireside chat saranno disponibili tramite webcast dal vivo sul sito web di REGENXBIO, con registrazioni accessibili per circa 30 giorni dopo ogni presentazione.

REGENXBIO (Nasdaq: RGNX) ha anunciado su participación en cinco importantes conferencias para inversores durante marzo y abril de 2025. La compañía participará en presentaciones en formato fireside chat en:

  • La 45ª Conferencia Anual de Atención Médica de TD Cowen en Boston (5 de marzo, 1:10 p.m. ET)
  • La Conferencia Global de Atención Médica de Leerink Partners en Miami (11 de marzo, 9:20 a.m. ET)
  • La 27ª Conferencia Global de Atención Médica de Barclays en Miami (12 de marzo, 3:30 p.m. ET)
  • Día Virtual CNS de UBS (17 de marzo, 10:00 a.m. ET)
  • La Conferencia Virtual Inaugural de Oftalmología de RBC (3 de abril, 8:15 a.m. ET)

Se seleccionarán fireside chats que estarán disponibles a través de una transmisión en vivo en el sitio web de REGENXBIO, con grabaciones accesibles durante aproximadamente 30 días después de cada presentación.

REGENXBIO (Nasdaq: RGNX)는 2025년 3월과 4월에 열리는 다섯 개의 주요 투자자 회의에 참여한다고 발표했습니다. 회사는 다음과 같은 fireside chat 발표에 참여할 예정입니다:

  • TD Cowen의 제45회 연례 헬스케어 회의 보스턴에서 (3월 5일, 오후 1:10 ET)
  • Leerink Partners 글로벌 헬스케어 회의 마이애미에서 (3월 11일, 오전 9:20 ET)
  • 바클레이즈 제27회 글로벌 헬스케어 회의 마이애미에서 (3월 12일, 오후 3:30 ET)
  • UBS 가상 CNS의 날 (3월 17일, 오전 10:00 ET)
  • RBC 첫 번째 가상 안과 회의 (4월 3일, 오전 8:15 ET)

REGENXBIO (Nasdaq: RGNX) a annoncé sa participation à cinq grandes conférences pour investisseurs en mars et avril 2025. L'entreprise participera à des présentations sous forme de fireside chat lors des événements suivants :

  • La 45e Conférence Annuelle sur la Santé de TD Cowen à Boston (5 mars, 13h10 ET)
  • La Conférence Mondiale sur la Santé de Leerink Partners à Miami (11 mars, 9h20 ET)
  • La 27e Conférence Mondiale sur la Santé de Barclays à Miami (12 mars, 15h30 ET)
  • Journée Virtuelle CNS de UBS (17 mars, 10h00 ET)
  • La Conférence Virtuelle Inaugurale d'Ophtalmologie de RBC (3 avril, 8h15 ET)

Certains fireside chats seront disponibles via un webcast en direct sur le site web de REGENXBIO, avec des enregistrements accessibles pendant environ 30 jours après chaque présentation.

REGENXBIO (Nasdaq: RGNX) hat seine Teilnahme an fünf wichtigen Investorenkonferenzen im März und April 2025 bekannt gegeben. Das Unternehmen wird an Fireside-Chat-Präsentationen bei folgenden Veranstaltungen teilnehmen:

  • TD Cowens 45. jährliche Gesundheitskonferenz in Boston (5. März, 13:10 Uhr ET)
  • Leerink Partners globale Gesundheitskonferenz in Miami (11. März, 9:20 Uhr ET)
  • Barclays 27. jährliche globale Gesundheitskonferenz in Miami (12. März, 15:30 Uhr ET)
  • UBS Virtueller CNS-Tag (17. März, 10:00 Uhr ET)
  • RBC erste virtuelle Augenheilkunde-Konferenz (3. April, 8:15 Uhr ET)

Ausgewählte Fireside Chats werden über einen Live-Webcast auf der Website von REGENXBIO verfügbar sein, mit Aufzeichnungen, die etwa 30 Tage nach jeder Präsentation abrufbar sind.

Positive
  • None.
Negative
  • None.

ROCKVILLE, Md., Feb. 25, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:

TD Cowen's 45th Annual Health Care Conference
Fireside Chat: Wednesday, March 5 at 1:10pm ET
Location: Boston, MA

Leerink Partners Global Healthcare Conference
Fireside Chat: Tuesday, March 11 at 9:20am ET
Location: Miami, FL

Barclays 27th Annual Global Healthcare Conference 
Fireside Chat: Wednesday, March 12 at 3:30pm ET
Location: Miami, FL

UBS Virtual CNS Day
Fireside Chat: Monday, March 17 at 10:00am ET
Location: Virtual

RBC Inaugural Virtual Ophthalmology Conference 
Fireside Chat: April 3 at 8:15am ET
Location: Virtual

Live webcasts of select fireside chats can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

ABOUT REGENXBIO Inc.
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for rare and retinal diseases, including RGX-202 for the treatment of Duchenne, ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO's AAV Therapeutic platform, including Novartis' Zolgensma® for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.

Contacts:

Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
George E. MacDougall
Investor Relations
IR@regenxbio.com

(PRNewsfoto/REGENXBIO Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302385213.html

SOURCE REGENXBIO Inc.

FAQ

What investor conferences will RGNX attend in March 2025?

RGNX will attend four conferences in March 2025: TD Cowen Health Care (Boston), Leerink Partners Global Healthcare (Miami), Barclays Global Healthcare (Miami), and UBS Virtual CNS Day.

How long will RGNX conference webcasts be available for replay?

Webcasts of select fireside chats will be available for approximately 30 days following each presentation on REGENXBIO's website.

Which RGNX investor presentations will be virtual in 2025?

Two presentations will be virtual: the UBS Virtual CNS Day on March 17 and the RBC Inaugural Virtual Ophthalmology Conference on April 3, 2025.

What is the schedule for RGNX's Miami conference presentations in March 2025?

In Miami, RGNX will present at Leerink Partners Conference on March 11 at 9:20am ET and Barclays Conference on March 12 at 3:30pm ET.

Regenxbio

NASDAQ:RGNX

RGNX Rankings

RGNX Latest News

RGNX Stock Data

343.35M
45.50M
7.57%
92.62%
12.28%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
ROCKVILLE